DESIGN OF A CHIMERIC ACE-2/Fc-SILENT FUSION PROTEIN WITH ULTRAHIGH AFFINITY AND NEUTRALIZING CAPACITY FOR SARS-CoV-2 VARIANTS
B. Uhal, N. M. Bodie, D. Connolly, J. Chu
This paper designs a chimeric ACE-2/Fc-silent fusion protein with ultra-high affinity and neutralizing capacity against multiple SARS-CoV-2 variants.
Antibody Therapeutics · Jan 18, 2023Peer-reviewedMicrobiology